臨床泌尿器科70巻2号

2016年02月発行

特集 ここが知りたい! 筋層非浸潤性膀胱癌─エキスパートが答える日常診療の疑問点

〈経尿道的切除術 : TUR〉

生検の適応

著者： 島本力¹ 井上啓史¹

所属機関： ¹高知大学医学部泌尿器科学教室

ページ範囲：P.139 - P.143

文献概要

質問 : 上皮内癌（随伴CISを含む）の診断は誰を対象にどのような方法で検査するのがよいのでしょうか？

▶ポイント

・NMIBCにおいてCISの有無は，その予後に関わる重要な因子である．

・CISを疑う場合には，TUR-BT時に前立腺部尿道を含めたランダム生検が推奨される．

・従来の白色光と比較して，NBIやPDDなどの特殊光を用いることで，CISの診断率の大幅な改善が期待できる．

参考文献

1） Sylvester RJ, van der Meijden AP, Oosterlinck W, et al : Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables : a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49 : 466─5, discussion 75-7, 2006

2） 日本泌尿器科学会（編） : 膀胱癌診療ガイドライン2015年版. 医学図書出版, 東京, 2015

3） van der Meijden A, Oosterlinck W, Brausi M, et al : Significance of bladder biopsies in Ta,T1 bladder tumors : a report from the EORTC Genito-Urinary Tract Cancer Cooperative Group. EORTC-GU Group Superficial Bladder Committee. Eur Urol 35 : 267─271, 1999

4） Babjuk M, Burger M, Zigeuner R, et al : EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder : update 2013. Eur Urol 64 : 639─653, 2013

5） Kiemeney LA, Witjes JA, Heijbroek RP, et al : Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Members of the Dutch South-East Co-Operative Urological Group. Br J Urol 73 : 164─171, 1994

6） Thorstenson A, Schumacher MC, Wiklund NP, et al : Diagnostic random bladder biopsies : reflections from a population-based cohort of 538 patients. Scand J Urol Nephrol 44 : 11─19, 2010

7） May F, Treiber U, Hartung R, et al : Significance of random bladder biopsies in superficial bladder cancer. Eur Urol 44 : 47─50, 2003

8） Inoue K, Fukuhara H, Shimamoto T, et al : Comparison between intravesical and oral administration of 5-aminolevulinic acid in the clinical benefit of photodynamic diagnosis for nonmuscle invasive bladder cancer. Cancer 118 : 1062─1074, 2012

9） Kriegmair M, Baumgartner R, Knuechel R, et al : Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 44 : 836─841, 1994

10） Kamat AM, Hegarty PK, Gee JR, et al : ICUD-EAU International Consultation on Bladder Cancer 2012 : Screening, diagnosis, and molecular markers. Eur Urol 63 : 4─15, 2013

11） Tatsugami K, Kuroiwa K, Kamoto T, et al : Evaluation of narrow-band imaging as a complementary method for the detection of bladder cancer. J Endourol 24 : 1807─2011, 2010

12） Zheng C, Lv Y, Zhong Q, et al : Narrow band imaging diagnosis of bladder cancer : systematic review and meta-analysis. BJU Int 110 : E680─687, 2012

13） Geavlete B, Stanescu F, Moldoveanu C, et al : NBI cystoscopy and bipolar electrosurgery in NMIBC management - An overview of daily practice. J Med Life 6 : 140─145, 2013

14） Naito S, van Rees Vellinga S and de la Rosette J : Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer : accession to the first milestone-enrollment of 600 patients. J Endourol 27 : 1─3, 2013

15） Malik Z and Lugaci H : Destruction of erythroleukaemic cells by photoactivation of endogenous porphyrins. Br J Cancer 56 : 589─595, 1987

16） Mowatt G, N’Dow J, Vale L, et al : Photodynamic diagnosis of bladder cancer compared with white light cystoscopy : Systematic review and meta-analysis. Int J Technol Assess Health Care 27 : 3─10, 2011

17） Shen P, Yang J, Wei W, et al : Effects of fluorescent light-guided transurethral resection on non-muscle-invasive bladder cancer : a systematic review and meta-analysis. BJU Int 110 : E209─215, 2012

18） Rink M, Babjuk M, Catto JW, et al : Hexyl aminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer : a critical review of the current literature. Eur Urol 64 : 624─638, 2013

19） Burger M, Grossman HB, Droller M, et al : Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy : a meta-analysis of detection and recurrence based on raw data. Eur Urol 64 : 846─854, 2013

20） Matzkin H, Soloway MS and Hardeman S : Transitional cell carcinoma of the prostate. J Urol 146 : 1207─1212, 1991

21） Mungan MU, Canda AE, Tuzel E, et al : Risk factors for mucosal prostatic urethral involvement in superficial transitional cell carcinoma of the bladder. Eur Urol 48 : 760─763, 2005

22） Liedberg F, Anderson H, Blackberg M, et al : Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection. Scand J Urol Nephrol 41 : 290─296, 2007

23） Sakamoto N, Tsuneyoshi M, Naito S, et al : An adequate sampling of the prostate to identify prostatic involvement by urothelial carcinoma in bladder cancer patients. J Urol 149 : 318─321, 1993